Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · Real-Time Price · USD
20.03
-0.50 (-2.44%)
At close: Jun 12, 2026, 4:00 PM EDT
20.09
+0.06 (0.30%)
After-hours: Jun 12, 2026, 4:10 PM EDT
Amphastar Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Amphastar Pharmaceuticals stock has a consensus rating of "Hold" and an average price target of $22.83. The average 1-year stock price forecast is 13.98% higher than the current stock price, while the lowest is $19 (-5.14%) and the highest is $30 (+49.78%).
Price Target: $22.83 (+13.98%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Amphastar Pharmaceuticals stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Hold | 4 | 4 | 4 | 5 | 7 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Reiterates $23 → $20 | Hold | Reiterates | $23 → $20 | -0.15% | Jun 3, 2026 |
| Wells Fargo | Wells Fargo | Hold Downgrades $30 → $19 | Hold | Downgrades | $30 → $19 | -5.14% | May 14, 2026 |
| Piper Sandler | Piper Sandler | Hold Maintains $25 → $21 | Hold | Maintains | $25 → $21 | +4.84% | May 11, 2026 |
| Needham | Needham | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | May 8, 2026 |
| Bank of America Securities | Bank of America Securities | Hold Reiterates $28 → $25 | Hold | Reiterates | $28 → $25 | +24.81% | May 8, 2026 |
Financial Forecast
Revenue This Year
746.79M
from 719.89M
Increased by 3.74%
Revenue Next Year
788.44M
from 746.79M
Increased by 5.58%
EPS This Year
2.68
from 3.25
Decreased by -17.53%
EPS Next Year
3.14
from 2.68
Increased by 17.24%
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 759.3M | ||
| Avg | 746.8M | ||
| Low | 730.6M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 5.5% | ||
| Avg | 3.7% | ||
| Low | 1.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 2.68 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | -17.5% | ||
| Low | - |